Invited Speaker | Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials
Dr. Alisar S. Zahr is the Director of Research and Clinical Development at Revision Skincare®. As head of the department, her responsibilities include researching novel ingredients and technology for incorporation into Revision’s new product pipeline, conducting, analyzing, and publishing clinical studies to further cement Revision Skincare’s science. Dr. Zahr is considered a subject matter expert in formulation of sunscreens and anti-aging treatments. Throughout her career in the personal cosmetics industry, she has formulated and successfully brought products to the market, such as Neutrogena, Roc, Clean & Clear, Aveeno, and eltaMD. As evident from Dr. Zahr’s prior work experience, she is passionate about engineering solutions for unmet needs in dermatology and is focused on creating products that improve patient’s long term skin health.
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.